Literature DB >> 11062289

Frequencies of certain complement protein alleles and serum levels of anti-heat-shock protein antibodies in cerebrovascular diseases.

J Kramer1, P Harcos, Z Prohászka, L Horváth, I Karádi, M Singh, A Császár, L Romics, G Füst.   

Abstract

BACKGROUND AND
PURPOSE: A strong correlation exists between the intensity of atherosclerotic alterations in different arteries. Marked differences exist, however, in the age and sex distribution and risk factors for coronary heart disease (CHD) and cerebrovascular disease (CVD). We therefore performed genetic and immunologic studies in patients with CVD.
METHODS: We studied 292 patients with CVD (stroke or transient ischemic attack) and as control either 198 healthy blood donors and 485 healthy elderly (aged >60 years) people (genetic study) or 94 blood donors aged 45 to 60 years and 49 healthy elderly (aged >60 years) people (anti-heat-shock protein [hsp] measurements). Allele frequencies of 3 genes (C4A, C4B, and C3) encoding proteins of the complement system were determined by electrophoresis and immunofixation. Serum concentration of autoantibodies against 60-kDa heat-shock protein (anti-hsp60) was measured by the enzyme-linked immunosorbent assay method.
RESULTS: Marked differences were observed between CVD patients and controls in the genetic studies. In the CVD patients aged >60 years, the frequency (11.3%) of the deficient allele of the C4B gene (C4B*Q0) was significantly (P:=0.0003) higher than that of the healthy controls (5.4%). By contrast, in the group aged 45 to 60 years, the frequency of the C4B*Q0 allele was lower in patients than in controls. Serum concentration of anti-hsp60 in the CVD patients did not differ from control values.
CONCLUSIONS: In previous studies C4B*Q0 frequency was reported to be higher in CHD patients aged 45 to 60 years than in aged-matched controls. Moreover, high anti-hsp60 levels were found in CHD patients. These findings contrast with our present report of lower frequency of C4B*Q0 in CVD patients. Therefore, genetic and immunologic factors may at least partly explain the differences between the natural history and risk factors of CHD and CVD.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11062289     DOI: 10.1161/01.str.31.11.2648

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  11 in total

1.  Smoking and a complement gene polymorphism interact in promoting cardiovascular disease morbidity and mortality.

Authors:  G J Arason; J Kramer; B Blaskó; R Kolka; P Thorbjornsdottir; K Einarsdóttir; A Sigfúsdóttir; S T Sigurdarson; G Sigurdsson; Z Rónai; Z Prohászka; M Sasvári-Székely; S Bödvarsson; G Thorgeirsson; G Füst
Journal:  Clin Exp Immunol       Date:  2007-04-11       Impact factor: 4.330

2.  Elevated levels of autoantibodies against DNAJC2 in sera of patients with atherosclerotic diseases.

Authors:  Yoichi Yoshida; Xiao-Meng Zhang; Hao Wang; Toshio Machida; Seiichiro Mine; Eiichi Kobayashi; Akihiko Adachi; Tomoo Matsutani; Ikuo Kamitsukasa; Takeshi Wada; Akiyo Aotsuka; Katsuro Iwase; Go Tomiyoshi; Rika Nakamura; Natsuko Shinmen; Hideyuki Kuroda; Hirotaka Takizawa; Koichi Kashiwado; Hideo Shin; Yuichi Akaogi; Junichiro Shimada; Eiichiro Nishi; Mikiko Ohno; Minoru Takemoto; Koutaro Yokote; Kenichiro Kitamura; Yasuo Iwadate; Takaki Hiwasa
Journal:  Heliyon       Date:  2020-08-19

3.  Impaired humoral immune response against mycobacterial 65-kDa heat shock protein (HSP65) in patients with inflammatory bowel disease.

Authors:  Laszló Bene; George Füst; Zoltán Huszti; Zsolt Hernádi; Béla Fekete; Márta Mészáros; Amarilla Veres; Agota Kovács; Kata Miklós; Mahavir Singh; László Romics; Zoltán Prohászka
Journal:  Dig Dis Sci       Date:  2002-07       Impact factor: 3.199

4.  Serum anti-DIDO1, anti-CPSF2, and anti-FOXJ2 antibodies as predictive risk markers for acute ischemic stroke.

Authors:  Takaki Hiwasa; Hao Wang; Ken-Ichiro Goto; Seiichiro Mine; Toshio Machida; Eiichi Kobayashi; Yoichi Yoshida; Akihiko Adachi; Tomoo Matsutani; Mizuki Sata; Kazumasa Yamagishi; Hiroyasu Iso; Norie Sawada; Shoichiro Tsugane; Mitoshi Kunimatsu; Ikuo Kamitsukasa; Masahiro Mori; Kazuo Sugimoto; Akiyuki Uzawa; Mayumi Muto; Satoshi Kuwabara; Yoshio Kobayashi; Mikiko Ohno; Eiichiro Nishi; Akiko Hattori; Masashi Yamamoto; Yoshiro Maezawa; Kazuki Kobayashi; Ryoichi Ishibashi; Minoru Takemoto; Koutaro Yokote; Hirotaka Takizawa; Takashi Kishimoto; Kazuyuki Matsushita; Sohei Kobayashi; Fumio Nomura; Takahiro Arasawa; Akiko Kagaya; Tetsuro Maruyama; Hisahiro Matsubara; Minako Tomiita; Shinsaku Hamanaka; Yushi Imai; Tomoo Nakagawa; Naoya Kato; Jiro Terada; Takuma Matsumura; Yusuke Katsumata; Akira Naito; Nobuhiro Tanabe; Seiichiro Sakao; Koichiro Tatsumi; Masaaki Ito; Fumiaki Shiratori; Makoto Sumazaki; Satoshi Yajima; Hideaki Shimada; Mikako Shirouzu; Shigeyuki Yokoyama; Takashi Kudo; Hirofumi Doi; Katsuro Iwase; Hiromi Ashino; Shu-Yang Li; Masaaki Kubota; Go Tomiyoshi; Natsuko Shinmen; Rika Nakamura; Hideyuki Kuroda; Yasuo Iwadate
Journal:  BMC Med       Date:  2021-06-09       Impact factor: 8.775

5.  Real-time PCR quantification of human complement C4A and C4B genes.

Authors:  Agnes Szilagyi; Bernadett Blasko; Denes Szilassy; George Fust; Maria Sasvari-Szekely; Zsolt Ronai
Journal:  BMC Genet       Date:  2006-01-10       Impact factor: 2.797

6.  Elevated Adiponectin Antibody Levels in Sera of Patients with Atherosclerosis-Related Coronary Artery Disease, Cerebral Infarction and Diabetes Mellitus.

Authors:  Takaki Hiwasa; Xiao-Meng Zhang; Risa Kimura; Mikiko Ohno; Po-Min Chen; Eiichiro Nishi; Koh Ono; Takeshi Kimura; Ikuo Kamitsukasa; Takeshi Wada; Akiyo Aotsuka; Seiichiro Mine; Hirotaka Takizawa; Koichi Kashiwado; Minoru Takemoto; Kazuki Kobayashi; Harukiyo Kawamura; Ryoichi Ishibashi; Koutaro Yokote; Rika Nakamura; Go Tomiyoshi; Natsuko Shinmen; Hideyuki Kuroda
Journal:  J Circ Biomark       Date:  2016-04-07

Review 7.  Roles of Extracellular HSPs as Biomarkers in Immune Surveillance and Immune Evasion.

Authors:  Eman A Taha; Kisho Ono; Takanori Eguchi
Journal:  Int J Mol Sci       Date:  2019-09-17       Impact factor: 5.923

8.  Association of serum levels of antibodies against ALDOA and FH4 with transient ischemic attack and cerebral infarction.

Authors:  Hao Wang; Hao Lu; Xiao-Meng Zhang; Ken-Ichiro Goto; Eiichi Kobayashi; Yoichi Yoshida; Akihiko Adachi; Tomoo Matsutani; Yasuo Iwadate; Seiichiro Mine; Toshio Machida; Mizuki Sata; Kazumasa Yamagishi; Hiroyasu Iso; Norie Sawada; Shoichiro Tsugane; Ikuo Kamitsukasa; Takeshi Wada; Akiyo Aotsuka; Kazuo Sugimoto; Hirotaka Takizawa; Koichi Kashiwado; Hideo Shin; Go Tomiyoshi; Rika Nakamura; Natsuko Shinmen; Hideyuki Kuroda; Anding Xu; Takaki Hiwasa
Journal:  BMC Neurol       Date:  2021-07-09       Impact factor: 2.474

Review 9.  Complement in the Homeostatic and Ischemic Brain.

Authors:  Ali Alawieh; Andrew Elvington; Stephen Tomlinson
Journal:  Front Immunol       Date:  2015-08-12       Impact factor: 7.561

10.  Investigation of complement component C4 copy number variation in human longevity.

Authors:  Friederike Flachsbart; Amke Caliebe; Femke-Anouska Heinsen; Tom Hemming-Karlsen; Stefan Schreiber; Andre Franke; Almut Nebel
Journal:  PLoS One       Date:  2014-01-22       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.